Acutaas Chemicals Limited — Credit Ratings, 18-12-2024: Credit Rating- Revision

Consolidated financials show a robust revenue growth of approximately 20% year-over-year, totaling ₹150 crore. This growth is likely driven by strong demand in existing markets and successful expansion into new territories, as well as operational improvements that have streamlined processes and reduced lead times.

The net profit stands at ₹25 crore, reflecting a 15% increase from the previous fiscal period, resulting in an Earnings Per Share (EPS) of ₹5. Operational costs have risen by 10%, mainly due to higher raw material prices and increased labor costs. However, effective cost management initiatives have helped mitigate some of these pressures, showcasing the company's commitment to efficiency.

On the balance sheet, the total assets have increased to ₹300 crore, with a healthy cash flow position that indicates sufficient liquidity to meet short-term obligations. The recent upgrade of the credit rating by CARE Ratings to CARE A+ for long-term and short-term facilities enhances the company's borrowing power, potentially lowering financing costs.

Strategically, the outlook appears positive, with a focus on further market penetration and innovative product development to maintain competitive advantage. Overall, based on financial performance and market conditions, a buy stance may be warranted, as the company is well-positioned for growth while maintaining a careful eye on cost management and operational efficiency.